Phase I dose-escalation trial of the oral AKT inhibitor uprosertib in combination with the oral MEK1/MEK2 inhibitor trametinib in patients with solid tumors
Titel:
Phase I dose-escalation trial of the oral AKT inhibitor uprosertib in combination with the oral MEK1/MEK2 inhibitor trametinib in patients with solid tumors
Auteur:
Tolcher, Anthony W. Kurzrock, Razelle Valero, Vincente Gonzalez, Rene Heist, Rebecca S. Tan, Antoinette R. Means-Powell, Julie Werner, Theresa L. Becerra, Carlos Wang, Chenxi Leonowens, Cathrine Kalyana-Sundaram, Shanker Kleha, Joseph F. Gauvin, Jennifer D’Amelio, Anthony M. Ellis, Catherine Ibrahim, Nageatte Yan, Li